Range Biotechnologies

Range Biotechnologies is a biotechnology and health care startup, founded in 2022 in the United States. The company aims to revolutionize human health through the unlocking of translational proteomics. Their slogan, "Translational proteomics for the next stage of human health," reflects their commitment to advancing the field of proteomics for the betterment of human well-being. In June 2023, Range Biotechnologies successfully secured a $5.20M Seed Round investment. This funding round saw participation from a diverse group of investors, including Pear Ventures, Pillar, Civilization Ventures, Four Cities Capital, Page One Ventures, Hawktail Management, and Artis Ventures (AV). This investment not only paves the way for the company's growth and development but also signifies the confidence that prominent venture capital firms have in Range Biotechnologies' vision and potential.